LIGAFIX interference screws

LIGAFIX system
LIGAFIX interference screws have been designed to ensure graft fixation for anterior cruciate ligament (ACL) reconstruction.

Concept

LIGAFIX screws are characterized by their controlled resorption and their availability in several compositions and shapes. LIGAFIX 30 are rather used for fixing patellar tendon grafts. Their high mechanical strength provide a strong fixation for bone plugs, particularly in torsion and flexion. LIGAFIX 60 have been designed specifically for soft tissue transplants. Containing 60% of osteoconductive Tricalcium Phosphate, they provide an optimal healing inside the tunnels.

Materials

LIGAFIX screws have been designed in Duosorb, composite material made of Tricalcium Phosphate (β-TCP) and Polylactic Acid DL (PLDL). This combination provide an osteoconductive, bioabsorbable and bioactive material while providing and excellent mechanical strength and elasticity.
LIGAFIX 30 screws are composed of 30% β-TCP and 70% of PLDL.
LIGAFIX 60 screws are composed of 60% β-TCP and 40% of PLDL. This innovative material is only manufactured by SBM.

Advantages

• • Implant adapted to all kinds of techniques;
  • Round or flat head screws;
  • Osteoconductive, absorbable and bioactive;
  • No inflammatory reactions thanks to an appropriate amount of β-TCP;
  • Instruments sets for all kinds of techniques;
  • MRI and X-ray compatible.

Solutions for BioSurgery since 1991

SBM (Science & BioMaterials) specializes in the design, manufacture and marketing of synthetic biological implants for bone, tendons and ligaments reconstruction and healing.
With almost 30 years’ experience, SBM brings new products to the market each year whose effectiveness and reputation are recognized in over 45 countries around the world as well as in Lithuania, official distributor – Abili, JSC. SBM offers leading orthopedic surgery systems:

• bone detects fillingi,
• osteotomies around the knee,
• ligament and tendons reconstruction,
• shoulder rotator cuff repair.

SBM was the first European company to be certified for CE marking for its range of synthetic bone augmentation implants (pure Tricalcium Phosphate – Biosorb) in Europe in 1993, and obtained approval from the U.S. FDA (Food and Drug Administration) in 2003.